Possible association of interleukin-2 treatment with depression and suicide
Year: 1993
Type: article
Study design: Case Report
Abstract: Immunomodulatory agents for the treatment of certain oncologic disorders are rapidly moving from the research laboratory into clinical practice. These agents may not be void of potential neuropsychiatric sequelae. The following clinical report concerns a previously nondepressed patient with no history of psychiatric disorders who became depressed and killed himself while being treated with interleukin-2. It is important that consulting psychiatrists be sensitive to acute emotional changes in cancer patients taking immunomodulatory agents.
Source: Journal of Osteopathic Medicine
Authors: David A. Baron, Thomas Hardie, Steven Baron
Language: English
Subfield: Biological Psychiatry
Field: Neuroscience
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid:
OpenAlex ID: W2206907718
